CRBU vs MRNA · rev $3.9M vs rev $145.0M
Caribou Biosciences Inc (CRBU) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
CRBU currently screens at market cap $190.4M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the CRBU and MRNA stock pages for the full models.
Not investment advice.